AFP Monoclonal Antibody

說明書

中文名稱：

AFP鼠單克隆抗體
貨號：

CSB-MA027711E0m
規格：

￥1320
圖片：
Immunohistochemistry of paraffin-embedded human liver using CSB-MA027711E0m in 30μg/ml dilute concentrations.

Immunohistochemistry of paraffin-embedded human liver cancer using CSB-MA027711E0m in 30μg/ml dilute concentrations.
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品描述：

甲胎蛋白（AFP）作為胚胎發育關鍵蛋白及肝癌診斷標志物，在腫瘤機制研究和生物標志物開發中具有重要價值。AFP Monoclonal Antibody（CUSABIO貨號：CSB-MA027711E0m）是一款經嚴格驗證的人源特異性單克隆抗體，采用雜交瘤技術制備，確保批次間穩定性和高親和力。該抗體經ELISA與IHC實驗驗證，適用于肝癌細胞系蛋白表達分析、腫瘤組織切片抗原定位等科研場景，可支持基礎研究中的靶點驗證及藥物開發模型構建。產品具有高靈敏度與低交叉反應特性，可在復雜樣本中精準識別AFP表位，為體外實驗提供可靠工具。適用于肝癌發生機制探索、腫瘤微環境研究及生物標志物篩選等方向，滿足分子生物學、病理學等多領域科研需求。通過優化純化工藝，確?？贵w低內毒素殘留，適配細胞實驗與免疫組化雙重平臺，助力精準科研數據獲取。
產品名稱：

mouse anti-Homo sapiens (Human) AFP monoclonal antibody
Uniprot No.：

P02771
基因名：

AFP
別名：

Afp antibody; AFPD antibody; Alpha fetoglobulin antibody; Alpha fetoprotein antibody; Alpha fetoprotein precursor antibody; Alpha-1-fetoprotein antibody; Alpha-fetoglobulin antibody; Alpha-fetoprotein antibody; alpha-fetoprotein; Hereditary persistence of; included antibody; FETA antibody; FETA_HUMAN antibody; Hereditary persistence of alpha fetoprotein antibody; HPAFP antibody
宿主：

mouse
反應種屬：

Human
免疫原：

AFP
免疫原種屬：

Homo sapiens (Human)
標記方式：

Non-conjugated
克隆類型：

monoclonal
抗體亞型：

IgG1
純化方式：

>95%,Protein G purified
克隆號：

4G2D2
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300 Constituents: 0.01M PBS, PH 7.4
產品提供形式：

liquid
應用范圍：

ELISA,IHC

推薦稀釋比：

Application	Recommended Dilution
IHC	1:50-1:500

Protocols：

ELISA Protocol
Immunohistochemistry (IHC) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Binds copper, nickel, and fatty acids as well as, and bilirubin less well than, serum albumin. Only a small percentage (less than 2%) of the human AFP shows estrogen-binding properties.
基因功能參考文獻：
1. Peak preoperative serum alpha-fetoprotein to total tumor volume predicts recurrence of hepatocellular carcinoma. PMID: 29284589
2. the results suggest that AFP may positively regulate cell proliferation by enhancing the apoptosis resistance via effect on TGF-beta and p53/Bax/caspase-3 signaling pathway in HepG2 cells. As such, the knockdown of AFP gene should be further investigated in vivo as a novel approach to hepatocellular carcinoma treatment. PMID: 30249880
3. Aberrant CTNNB1 expression was seen in a substantial proportion of our hepatocellular carcinoma (HCC) cases. CTNNB1-positive HCC was associated with normal AFP levels, unicentric tumors, well-differentiated histology, and an unfavorable outcome. PMID: 30082549
4. Elevated preoperative serum alpha-fetoprotein levels have predictive value for hepatocellular carcinoma survival. PMID: 28893428
5. Cases of ovarian ovarian Sertoli-Leydig cell tumors (SLCTs) with elevated serum AFP should be sampled extensively to look for foci of intestinal-type glands, the likely source of the alpha fetoprotein (AFP) elevation in some of these neoplasms. PMID: 28582340
6. In HBV-related cirrhosis, the combination of miR-122, AFP and PIVKA-II enables the identification of patients at higher risk of hepatocellular carcinoma development. PMID: 28650134
7. Examination of AFP over time has great predictive and prognostic value for managing advanced gastric cancer. For those with markedly elevated AFP, triplet regimens may be a better choice. PMID: 29375212
8. Low expression of AFP is associated with recurrence of hepatocellular carcinoma. PMID: 29572833
9. High-levels of PIVKA-II in at-risk patients is an indicator of hepatocellular carcinoma (HCC)development in two-year time. CONCLUSIONS: Our data showed that PIVKA-II effectively increases the detection rate of HCC was a valid complement to AFP and image examination in HCC surveillance PMID: 28863782
10. Unspecific AFP elevations occur in about 2% of pure testicular seminoma patients. PMID: 28668957
11. serum level in the second trimester an important indicator of fetal surface malformations PMID: 27771626
12. HCC [hepatocellular carcinoma] patients who are sero-positive for DCP [Des-gamma-carboxyprothrombin] and sero-negative for AFP[Alpha-fetoprotein] have significantly higher levels of serum ALT[alanine aminotransferase]; serum ALT levels may be of diagnostic importance in AFP-negative, HBV-related HCC [hepatitis B virus-related hepatocellular carcinoma] patients. PMID: 29192630
13. Higher baseline serum AFP levels independently predicted a lower sustained viral response to antivirals among patients with chronic hepatitis C. PMID: 17713163
14. Computer modeling shows the identification of potential binding sites of lysophospholipids (LP) receptors on the AFP third domain receptor binding fragment. AFP might bind not only to the LPL receptors, but also to LPLs themselves since AFP binds medium and long chain fatty acids. It is proposed that some of the activities ascribed to AFP might be due in part to the presence of bound LPLs and/or their receptors. [review] PMID: 26844573
15. AFP may be an important molecule acting against paclitaxel-inhibited proliferation and induced apoptosis in hepatocellular carcinoma cells via repressing the activity of caspase-3 and stimulating the expression of Ras and Survivin. PMID: 27255186
16. PIVKA II, when combined with AFP, may be considered as a screening test for hepatocellular carcinoma due to its high negative predictive value. PMID: 28652441
17. Identification of the distinct impact of circulating tumor derived AFP on NK-cell function and viability may be crucial to developing a strategy to ameliorate hepatocellular carcinoma patient NK-cell functional deficits. PMID: 28468916
18. The detection of ALT, AFP, AFP-L3, and GP73 has a certain guiding significance to predict the risk of hepatocellular carcinoma in hepatic cirrhosis patients PMID: 28540298
19. Antibody therapy targeted at AFP-producing tumor cells showed an inhibitory effect on the PI3K/AKT pathway via the liberation, restoration and functional stabilization of PTEN. PTEN simultaneously induced both P53 activation and intracellular translocation of GLUT1, since these are closely associated with PTEN. PMID: 28498467
20. Incorporation AFP status into the BCLC staging system to modify the recommended treatment of patients with stage C hepatocellular carcinoma. PMID: 27835609
21. we used alpha-fetoprotein (AFP), a specific liver cancer marker, as an example to determine whether peptide-MHC complexes can be targets for CAR T-cell therapy against solid tumors.in an established intraperitoneal liver cancer xenograft model, AFP-CAR T cells showed robust antitumor activity PMID: 27535982
22. miR-620, miR-1236 and miR-1270 are critical factors in the post-transcriptional regulation of AFP in hepatitis B infected hepatoma cells. Icaritin can counteract the effect of HBV. PMID: 27835879
23. BWS registries and prospective clinical studies will assess the most appropriate means to screen for hepatoblastoma, whether aFP-screened patients have additional survival benefit over patients screened by US only, and whether the outcome is improved by earlier detection PMID: 28211991
24. p55PIK significantly stimulated the expression of AFP by activating NF-kappaB signaling pathway in hepatocellular carcinoma cells. PMID: 28970114
25. Irregular MIP pattern by CEUS and high level of serum AFP-L3 were independent risk factors for poor outcome after successful RFA. The Patients with these findings should be considered as special high-risk group in early-stage HCC. PMID: 27748052
26. our data suggest that HBeAg seroconversion and liver cirrhosis are associated with the occurrence of HCC and that a surveillance system with regular measurement of AFP to watch for the occurrence of HCC may be mandatory for children and young patients with chronic HBV infection. PMID: 27748053
27. We could demonstrate in our cohort the superior detection of early stage HCC with the combined use of the respective biomarkers and in particular GALAD even in AFP-negative tumors. PMID: 27936479
28. A correlation was found between serum AFP concentration and age in extremely low-birthweight infants (ELBWI), and the 95%CI of serum AFP concentration was determined for ELBWI up to 2 years after birth. PMID: 27400853
29. rAFP promoted growth of the human HCC cells, antagonize paclitaxel inhibition of HCC cell proliferation, suppress expression of active caspase-3, and promote expression of Ras and survivin. PMID: 28554567
30. Measurements of serum alpha-fetoprotein (AFP) levels could be helpful in detecting progression or recurrence in treated patients with hepatitis B virus (HBV) - hepatocellular carcinoma (HCC) and normal alanine aminotransferase (ALT). PMID: 27304617
31. AFP mRNA level is in enriched circulating tumor cells from patients with metastatic hepatocellular carcinoma. PMID: 27160647
32. High serum AFP levels were significantly associated with the prevalence of metabolic syndrome in a Chinese asymptomatic population. PMID: 27121855
33. Contrary to expectation, Chronic Hepatitis B patients with current or recent exposure to NA therapy showed poorer performance of AFP during hepatocellular carcinoma surveillance PMID: 27997559
34. Protein induced by vitamin K absence or antagonist-II showed higher area under the curve than alpha-fetoprotein for diagnosis of hepatitis B virus-related hepatocellular carcinoma patients (0.901 vs 0.788).We conclude that Combining alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II may improve the diagnostic value for early detection of hepatocellular carcinoma. PMID: 28621228
35. AFP expression turned on prior to expression of Oct4, Klf4, Sox2 and c-myc, and the stemness markers CD44, CD133 and EpCAM in the normal human liver L-02 cell line or CHL cell lines upon transfection with MCV-HBx vectors. HBx stimulates AFP expression to induce natural reprogramming of liver cells, and AFP plays a critical role in promoting the initiation of HCC progenitor/stem cells. PMID: 27925189
36. analysis of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation PMID: 27688662
37. Lower post-treatment AFP levels and HCV genotype 2 significantly correlated with liver fibrosis regression after sustained virological response. PMID: 27123974
38. Increased expression of AFP resulted in the upregulation of beta-catenin mRNA and protein levels, while knockdown of AFP with AFP shRNA led to significantly decreased beta-catenin mRNA and protein levels in hepatocellular carcinoma cells. PMID: 27924522
39. serum level differentiates hepatocellular carcinoma from liver cirrhosis, especially when combined with acarboxyprothrombin PMID: 28296720
40. soluble alpha-fetoprotein is a marker for Fanconi anemia; FANC proteins form multi-protein complexes with BRCA proteins and are involved in homologous DNA repair [review] PMID: 27690720
41. Studies indicate that the experimental data on the carboxy-terminal third domain of alpha-fetoprotein (AFP-3D) interaction with cell cycle proteins in cultured MCF-7 breast cancer cells were consistent with the "in silico" findings. PMID: 27448301
42. we evaluated the clinical performance of LOCItrade mark-based tumor marker assays CEA, CA19-9, CA15-3, CA125 and AFP in patients with gastrointestinal cancer and demonstrated their high diagnostic power PMID: 28011514
43. The definitive endoderm and foregut endoderm differentiation capabilities of Wnt pathway-modulated cells were determined based on the expression levels of the endodermal transcription factors SOX17 and FOXA2 and those of the transcription activator GATA4 and the alpha-fetoprotein (AFP) gene, respectively. PMID: 26861571
44. Suggest elevated serum AFP levels may have diagnostic value for early stage hepatocellular carcinoma in Korean patients. PMID: 26767857
45. AFP promoted hepatocellular carcinoma cell invasion and metastasis via up-regulating expression of metastasis-related proteins. PMID: 26756858
46. Interference of AFP reduced AGS gastric cancer cell invasion and metastasis by enhancing anoikis sensitivity. PMID: 26986949
47. High serum alpha-fetoprotein is associated with colon cancer. PMID: 26976278
48. High serum AFP is associated with hepatitis B virus infection-related hepatocellular carcinoma. PMID: 26784252
49. Elevated insulin resistance, leptin, serum iron, ferritin, mean platelet volume, NLR, and advanced fibrosis, as well as decreased platelet count and serum albumin, are independently associated with an elevated AFP level in chronic hepatitis C. PMID: 26618566
50. VEGF could be a potential biomarker for HCC, while AFP could be used to distinguish between patients with HCC and cirrhosis or HCV. PMID: 26782388
顯示更多

收起更多
相關疾?。?/div>
Alpha-fetoprotein deficiency (AFPD); Alpha-fetoprotein, hereditary persistence (HPAFP)
亞細胞定位：

Secreted.
蛋白家族：

ALB/AFP/VDB family
組織特異性：

Plasma. Synthesized by the fetal liver and yolk sac.
數據庫鏈接：

HGNC: 317

OMIM: 104150

KEGG: hsa:174

STRING: 9606.ENSP00000379138

UniGene: Hs.518808

Most popular with customers

YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
VIM Recombinant Monoclonal Antibody

Applications: ELISA, IHC, IF

Species Reactivity: Human
VDR Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human